Report

EYEG: FDA Approves IDE. We Like Chances of Success of Upcoming OBG-PRK Pivotal Study

Underlying
EYEGATE PHARMACEUTICALS INC

Provider
Zacks
Zacks

​Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch